Gene: PCOLCE
Official Full Name: procollagen C-endopeptidase enhancerprovided by HGNC
Gene Summary: Fibrillar collagen types I-III are synthesized as precursor molecules known as procollagens. These precursors contain amino- and carboxyl-terminal peptide extensions known as N- and C-propeptides, respectively, which are cleaved, upon secretion of procollagen from the cell, to yield the mature triple helical, highly structured fibrils. This gene encodes a glycoprotein which binds and drives the enzymatic cleavage of type I procollagen and heightens C-proteinase activity. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36171 | PCOLCE Knockout cell line (HeLa) | Human | PCOLCE | 1:3~1:6 | Negative | Online Inquiry |
KO36172 | PCOLCE Knockout cell line (HCT 116) | Human | PCOLCE | 1:2~1:4 | Negative | Online Inquiry |
KO36173 | PCOLCE Knockout cell line (HEK293) | Human | PCOLCE | 1:3~1:6 | Negative | Online Inquiry |
KO36174 | PCOLCE Knockout cell line (A549) | Human | PCOLCE | 1:3~1:4 | Negative | Online Inquiry |
PCOLCE Gene Knockout Cell Lines are genetically engineered cell lines that have been meticulously modified to disrupt the expression of the PCOLCE gene, which encodes the pro-collagen C-endopeptidase enhancer. These cell lines serve as invaluable tools in research, enabling scientists to study the biological roles and dysregulations of PCOLCE in extracellular matrix remodeling and tissue fibrosis. The technology behind these knockout cell lines employs cutting-edge CRISPR-Cas9 gene-editing techniques, providing a precise approach to gene disruption.
The primary function of PCOLCE in the extracellular environment involves enhancing the activity of pro-collagen peptidases, which are crucial for collagen maturation and turnover. By studying these knockout cell lines, researchers can elucidate the mechanistic pathways through which PCOLCE influences collagen synthesis and degradation, offering insights into conditions associated with abnormal collagen metabolism, such as fibrotic diseases and aging.
In clinical and research settings, the availability of PCOLCE Gene Knockout Cell Lines opens avenues for investigating therapeutic targets and developing novel treatment strategies. Unlike alternative models or methods that may lack specificity or introduce variability, these knockout cell lines provide a stable and reproducible system to explore gene function within relevant biological contexts.
Furthermore, the application of these cell lines can facilitate high-throughput screening of small molecules or biologics aimed at modulating collagen-related pathologies. For researchers and clinicians alike, the ability to efficiently manipulate PCOLCE signaling pathways presents a substantial opportunity to innovate and discover new interventions.
Our company prides itself on being at the forefront of genetic engineering technology, with a dedicated focus on providing high-quality, scientifically validated products that empower the research community. By choosing PCOLCE Gene Knockout Cell Lines, you are investing in reliable and effective tools designed to enhance scientific exploration and strengthen discoveries in regenerative medicine and tissue engineering.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.